Evotec’s Translational Biomarkers Strategy Platform provides end-to-end expertise in designing clinically relevant biomarker strategies across therapeutic areas and modalities. By aligning discovery, clinical development, and regulatory requirements, the platform delivers tailored biomarker packages, indication selection support, and IND-ready assay plans. With expert consultancy and access to a global KOL network, Evotec enables patient-centric trials and drives confident clinical decisions.
